J IRAN CHEM SOC
cm-1) mmax: 3444 (OH), 3028 (CH–ar.), 2978, 2933, 2873
(CH–aliph.), 1615 (C=O), 1436, 1383, 1267, 1110.
5,50-((3-Hydroxyphenyl)methylene)bis(1,3-diethyl-6-
hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (3dd0)
1
Colorless solid (70 %), mp = 244 °C. H NMR (CDCl3,
Triethylammonium 5-((6-hydroxy-1,3-dimethyl-2,4-dioxo-
1,2,3,4-tetrahydropyrimidin-5-yl)(2-nitrophenyl)
methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-
300 MHz) d: 14.00 (bs, 1H, OH), 8.06 (bs, 2H, 2 OH), 7.19
(t, 1H, J = 7.8 Hz, CH–ar.), 6.71 (d, 2H, J = 7.5 Hz, CH–
ar.), 6.64 (s, 1H, CH–ar.), 5.63 (s, 1H, CH-aliph.),
4.58–4.70 (m, 8H, 4 NCH2CH3), 1.38 (t, 6H, J = 6.9 Hz, 2
CH3CH2N), 1.30 (t, 6H, J = 6.9 Hz, 2 CH3CH2N); 13C
NMR (CDCl3, 75 MHz) d: 12.0, 12.1, 34.8, 44.6, 45.1,
97.3, 113.5, 113.7, 118.8, 129.6, 137.7, 155.8, 162.2,
163.7, 174.6; FT-IR (KBr, cm-1) mmax: 3458 (OH), 3020
(CH–ar.), 2982 (CH–aliph.), 2932 (CH–aliph.), 1620
(C=O), 1432, 1377, 1265, 1109.
tetrahydropyrimidin-4-olate (4ab0)
In a 10 mL tube, equipped with a magnetic stirrer, with
Teflon-faced screw cap, 0.15 g (0.96 mmol) 1,3-dimethyl
barbituric acid and 0.07 g (0.48 mmol) 2-nitrobenzaldehyde
were dissolved in 10 mL methanol and then 0.1 g (0.14 mL)
triethylamine was added to the solution at 0 °C. The reaction
mixture was stirred for 2 h at 0 °C to room temperature. The
progression of reaction was monitored by thin layer chro-
matography (TLC). After a few minutes, a crystalline white
solid precipitate was filtered off, washed with few milliliters
of methanol and dried (0.17 g, 90 % yield). Colorless solid,
5,50-((3,4,5-Trimethoxyphenyl)methylene)bis(1,3-diethyl-6-
hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (3ed0)
1
1
Colorless solid (70 %), mp = 155 °C. H NMR (CDCl3,
mp = 308 °C (decomps.). H NMR (CDCl3, 300 MHz) d:
300 MHz) d: 13.9 (bs, 1H, OH), 12.10 (bs, 1H, OH), 6.31
(s, 2H, CH–ar.), 5.62 (s, 1H, CH-aliph.), 4.50–4.70 (m, 8H,
4 NCH2CH3), 3.84 (s, 3H, OCH3), 3.76 (s, 6H, 2 OCH3),
1.37 (t, 6H, J = 6.9 Hz, 2 CH3CH2N), 1.30 (t, 6H,
J = 6.9 Hz, 2 CH3CH2N); 13C NMR (CDCl3, 75 MHz) d:
12.0, 12.1, 34.9, 44.5, 45.2, 56.4, 60.9, 97.5, 104.1, 131.1,
16.2 (bs, 1H, OH), 9.62 (bs, 1H, NH), 7.24–7.44 (m, 4H,
(CH–ar.)), 6.40 (s, 1H, CH-aliph.), 3.36–3.51 (m, 6H, 3 –
CH2–), 3.27 (s, 12H, 4 NCH3), 1.33 (t, 9H, J = 6.9 Hz, 3
CH3CH2); 13C NMR (CDCl3, 75 MHz) d: 8.7, 28.4, 32.0,
46.3, 50.6, 91.2, 123.7, 126.5, 129.9, 131.2, 136.1, 149.9,
151.9, 156.4, 163.8; FT-IR (KBr, cm-1) mmax: 3474 (OH),
3097 (CH–ar.), 2984 (CH–aliph.), 2947 (CH–aliph.), 1688
(C=O), 1615 (C=C ar.), 1526 (NO2).
137.1, 153.2, 162.2, 163.7, 174.6; FT-IR (KBr, cm-1) mmax
:
3436 (OH), 2977 (CH–aliph.), 2934 (CH–aliph.), 1619
(C=O), 1427, 1381, 1267, 1108.
Triethylammonium 5-((1,3-diethyl-6-hydroxy-4-oxo-2-
thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)
5,50-((4-Fluorophenyl)methylene)bis(1,3-diethyl-6-
hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (3fd0)
(2-nitrophenyl)methyl)-1,3-diethyl-6-oxo-2-thioxo-1,2,3,6-
tetrahydropyrimidin-4-olate (4ad0)
Colorless solid (70 %), mp = 189–190 °C. 1H NMR
(CDCl3, 300 MHz) d: 13.90 (bs, 1H, OH), 6.99–7.10 (m,
5H), 5.63 (s, 1H, CH-aliph.), 4.57–4.73 (m, 8H, 4
NCH2CH3), 1.38 (t, 6H, J = 6.9 Hz, 2 CH3CH2N), 1.30
(t, 6H, J = 6.9 Hz, 2 CH3CH2N); 13C NMR (CDCl3,
75 MHz) d: 11.99, 12.05, 34.4, 44.6, 45.2, 97.4, 115.2,
115.5, 127.9, 128.0, 131.1, 162.2, 163.2, 163.7, 174.6; FT-
IR (KBr, cm-1) mmax: 3432 (OH), 2975, 2918, 2849 (CH–
aliph.), 1620 (C=O), 1438, 1383, 1267, 1111.
1
Yellow solid (80 %), mp = 210 °C (decomps.). H NMR
(CDCl3, 300 MHz) d: 9.70 (bs, 1H, OH), 7.30–7.50 (m,
4H, CH–ar.), 6.42 (s, 1H, CH-aliph.), 4.37–4.59 (m, 8H, 4
NCH2CH3), 3.39–3.43 (m, 6H, 3 –CH2–), 2.30 (bs, 1H),
1.38 (t, 12H, J = 7.2 Hz, 4 CH3CH2N), 1.29 (t, 9H,
J = 6.9 Hz, 3 CH3CH2); 13C NMR (CDCl3, 75 MHz) d:
8.7, 12.2, 12.4, 32.2, 43.7, 44.1, 46.3, 96.1, 121.0, 123.9,
126.8, 129.7, 131.3, 150.1, 162.3, 162.6, 175.0; FT-IR
(KBr, cm-1) mmax: 3438 (OH, NH), 3083 (CH–ar.), 2979
(CH–aliph.), 2932 (CH–aliph.), 2871 (CH–aliph.), 1640
(C=O), 1614, 1526, 1434, 1380, 1267, 1103, 781.
5,50-(Phenylmethylene)bis(1,3-diethyl-6-hydroxy-2-thioxo-
2,3-dihydropyrimidin-4(1H)-one) (3gd0)
Colorless solid (70 %), mp = 188–190 °C. 1H NMR
(CDCl3, 300 MHz) d: 13.90 (bs, 1H), 7.29–7.36 (m, 3H,
CH–ar.), 7.14 (d, 2H, J = 7.2 Hz, CH–ar.), 6.76 (bs, 1H,
OH), 5.68 (s, 1H, CH-aliph.), 4.58–4.74 (m, 8H, 4
NCH2CH3), 1.39 (t, 6H, J = 6.9 Hz, 2 CH3CH2N), 1.31 (t,
6H, J = 6.9 Hz, 2 CH3CH2N); 13C NMR (CDCl3,
75 MHz) d: 11.98, 12.06, 34.9, 44.6, 45.1, 97.4, 126.3,
126.8, 128.5, 135.0, 162.0, 163.0, 174.6; FT-IR (KBr,
Triethylammonium 5-((6-hydroxy-1-methyl-2,4-dioxo-
1,2,3,4-tetrahydropyrimidin-5-yl)(2-nitrophenyl)methyl)-1-
methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate
(4ae0)
1
Yellow solid (70 %), mp = 318 °C (decomps). H NMR
(DMSO-d6, 300 MHz) d: 16.25 (bs, 1H, OH), 10.28 (s, 2H,
NH-BA), 8.75 (bs, 1H, NH-triethylammonium), 7.23–7.42
123